Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Autonomic Control in Bariatric Surgery
NCT00363935Phase 4Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2007
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine (4 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Cardiovascular stability. Planned start Jan 2007; status: withdrawn.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT00363935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363935.